Market Highlights: DNA forensics is refer as a branch of forensic science which focuses on the use of genetic material during investigation of criminal to answer the questions pertaining to the legal situations, which includes criminal and civil cases. DNA Forensics is the centralised source of news at national and international level and resources about the developments which are latest to the concerning DNA databases. DNA Forensics primarily provides forensic news, conference reports and interviews regarding the leading forensic professionals and law enforcement. DNA forensics is basically a science that uses the genetic material for identification of human, regrading the investigation in criminal and civil cases and healthcare research. Genetic material is obtained from the sources such as blood, saliva, bones, hair, tissue, teeth, and semen The market study is being classified by Type (Equipment and Supplies), by Application (Law Enforcement, Biodefense, Healthcare and Physical Security) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Key Players: The prominent players in the DNA Forensic are Lockheed Martin (United States), M2SYS Technology (United States), NEC (Japan), Safran (France), Agilent Technologies (United States), CrossResolve (United States), EasyDNA (United States), GE Healthcare (United States), Genetrack Biolabs (Canada) and homeDNAdirect (United Kingdom).
The Location, such as Laboratory Forensic Technology, is boosting the DNA Forensic market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.
Major Market Development Highlights Eurofins Scientific, a global scientific leader in bioanalytical testing and clinical diagnostics testing, Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (“Gentis”), a pioneer in genetic testing in Vietnam. The acquisition will further enhance Eurofins’ expansion in Asia and complement its global network of clinical diagnostics laboratories focused on specialized and advanced genetic testing. GE Healthcare announced the opening of a biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in Stevenage, UK. In the first half of 2019, the center will start producing a fiber-based purification platform, which has the potential to significantly improve efficiency in the purification steps of manufacturing biopharmaceuticals, gene therapies and viral vectors
Key Questions Answered in the Report What will the DNA Forensic Market size and the growth rate be in Future? What are the key factors driving the DNA Forensic Market? What are the key market trends and macro-economic impacting the growth of the DNA Forensic Market? What are the challenges to market growth? Who are the key vendors in the DNA Forensic Market? What are the market opportunities and threats faced by the vendors in the DNA Forensic Market? Trending factors influencing the market shares of the Players. What are the key outcomes of the five forces analysis of the DNA Forensic Market?
Research Methodology: The top-down and bottom-up approaches are used to estimate and validate the size of the Global DNA Forensic market. In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in DNA Forensic market. In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc. Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Goverment Regulatory, Research Organization and Others. This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc. Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.